title: Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.
authors.forename: Blanca
authors.initials: B
authors.lastname: Sanchez-Gonzalez
authors.forename: Jose C
authors.initials: JC
authors.lastname: Pascual-Ramirez
authors.forename: Pascual
authors.initials: P
authors.lastname: Fernandez-Abellan
authors.forename: Isabel
authors.initials: I
authors.lastname: Belinchon-Romero
authors.forename: Concepcion
authors.initials: C
authors.lastname: Rivas
authors.forename: Gloria
authors.initials: G
authors.lastname: Vegara-Aguilera
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000009:adverse effects*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics*; D011743:Pyrimidines / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate